Global Synthetic Biology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

List of Tables

The global demand for Synthetic Biology Market is presumed to reach the valuation of nearly USD 80.44 BN by 2030 from USD 11.59 BN in 2022 with a CAGR of 27.4% during the period of 2023-2030.

Synthetic biology is the technology which is developed from engineering, biology, computer science, and chemistry, but the approach was eventually changed towards therapeutics. Synthetic biology has its various applications which includes bio-based chemicals, industrial enzymes, biofuels, antibody production, vaccine and synthetic biology life science research. The biological systems are majorly advanced by molding the core components like genetic circuits, part of enzymes, and metabolic pathways. Initially, smaller devices are examined and their performance is tested before putting them into integrated systems. With the help of synthetic biology on the cellular, molecular and then genetic level, new medicines are been manufactured.

Market Dynamics:

Key players globally are investing in the synthetic biology attribute to the reason that the governmental bodies are focusing towards climate change and biomass. Many industries have initiated to turn their interest in the synthetic biology because of its large scale applications and potential to produce new editing techniques of the gene. These are some of the factors influencing the market to grow during the forecast period. DNA sequencing and DNA synthesis technologies and genetically engineered products are substituting the traditional medicines. Advanced design and computing systems in synthetic biology have completely changed the conventional approach of fighting against the genetic challenges and newer diseases. Government regulations and policies, biosafety, bio-war, and biosecurity issues are some of the factors hampering the market growth.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of synthetic biology.

Market Segmentation:

The entire synthetic biology market has been sub-categorized into application, product, and technology. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Tool

Oligonucleotides and Synthetic DNA
Enzymes
Cloning Technologies Kits
Synthetic Cells
Chassis Organisms
Xeno-nucleic Acids

By Technology

Gene Synthesis
Genome Engineering
Sequencing
Bloinformatics
Site-directed Mutagenesis
Cloning
Measurement and Modelling
Microfluidics
Nanotechnology

By Application

Medical Application
Artificial Tissue and Tissue Regeneration
Industrial Applications
Food & Agriculture
Environmental Applications

Regional Analysis:

This section covers regional segmentation which accentuates on current and future demand for synthetic biology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the synthetic biology market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies (US), Novozymes (Denmark), Ginkgo Bioworks (US), Amyris (US), Precigen Inc. (US), GenScript (China), Twist Bioscience (US), Synthetic Genomics (US), Codexis (US), Synthego (US), Creative Enzymes (US), Eurofins Scientific (Luxembourg). This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11211540

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . SYNTHETIC BIOLOGY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Tool
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL SYNTHETIC BIOLOGY MARKET ANALYSIS BY TOOL

5.1 Overview by Tool
5.2 Historical and Forecast Data
5.3 Analysis by Tool
5.4 Oligonucleotides And Synthetic DNA Historic and Forecast Sales by Regions
5.5 Enzymes Historic and Forecast Sales by Regions
5.6 Cloning Technologies Kits Historic and Forecast Sales by Regions
5.7 Synthetic Cells Historic and Forecast Sales by Regions
5.8 Chassis Organisms Historic and Forecast Sales by Regions
5.9 Xeno-nucleic Acids Historic and Forecast Sales by Regions

6 . GLOBAL SYNTHETIC BIOLOGY MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 Gene Synthesis Historic and Forecast Sales by Regions
6.5 Genome Engineering Historic and Forecast Sales by Regions
6.6 Sequencing Historic and Forecast Sales by Regions
6.7 Bloinformatics Historic and Forecast Sales by Regions
6.8 Site-directed Mutagenesis Historic and Forecast Sales by Regions
6.9 Cloning Historic and Forecast Sales by Regions
6.10. Measurement And Modelling Historic and Forecast Sales by Regions
6.11 Microfluidics Historic and Forecast Sales by Regions
6.12 Nanotechnology Historic and Forecast Sales by Regions

7 . GLOBAL SYNTHETIC BIOLOGY MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Medical Application Historic and Forecast Sales by Regions
7.5 Artificial Tissue And Tissue Regeneration Historic and Forecast Sales by Regions
7.6 Industrial Applications Historic and Forecast Sales by Regions
7.7 Food & Agriculture Historic and Forecast Sales by Regions
7.8 Environmental Applications Historic and Forecast Sales by Regions

8 . GLOBAL SYNTHETIC BIOLOGY MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE SYNTHETIC BIOLOGY COMPANIES

9.1. Synthetic Biology Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF SYNTHETIC BIOLOGY INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Thermo Fisher Scientific Inc. (US)
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Merck KGaA (Germany)
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Agilent Technologies (US)
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Novozymes (Denmark)
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Ginkgo Bioworks (US)
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Amyris (US)
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Precigen Inc. (US)
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. GenScript (China)
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Twist Bioscience (US)
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Synthetic Genomics (US)
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
10.13. Codexis (US)
- 10.13.1. Company Overview
- 10.13.2. Company Revenue
- 10.13.3. Products
- 10.13.4. Recent Developments
10.14. Synthego (US)
- 10.14.1. Company Overview
- 10.14.2. Company Revenue
- 10.14.3. Products
- 10.14.4. Recent Developments
10.15. Creative Enzymes (US)
- 10.15.1. Company Overview
- 10.15.2. Company Revenue
- 10.15.3. Products
- 10.15.4. Recent Developments
10.16. Eurofins Scientific (Luxembourg).
- 10.16.1. Company Overview
- 10.16.2. Company Revenue
- 10.16.3. Products
- 10.16.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies